<DOC>
	<DOCNO>NCT00856245</DOCNO>
	<brief_summary>Researchers hope learn add rituximab high dos chemotherapy stem cell transplantation help patient get rid lymphoma cell bone marrow stem cell collection .</brief_summary>
	<brief_title>Evaluate Rituximab Obtaining PCR Negative Leukapheresis Product Patients With Relapsed Follicular Lymphoma</brief_title>
	<detailed_description>Following first relapse , patient follicular type Non-Hodgkin 's lymphoma may option receive high dose chemotherapy follow autologous ( ) blood stem cell transplantation . One common cause relapse persistence lymphoma cell bone marrow collect stem cell product . Patients complete response traditional chemotherapy , great chance lymphoma return even receive high dose chemotherapy stem cell transplantation . In order improve response decrease relapse rate , additional therapy may use kill lymphoma cell use antibody transplantation . Antibodies protein make white cell body fight infection sometimes tumor . Rituxan ( rituximab ) antibody effective type lymphoma . Researchers report patient show improve response lower chance relapse use rituximab high dose chemotherapy autologous stem cell transplantation . It unknown effective rituximab clear persistence minimal remain disease patient follicular lymphoma .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Patients biopsyproven refractory CD20+ Follicular lymphoma transplant eligible mantle cell lymphoma CR1 later . Patients must transplant eligible per KUCC BMT SOP chemosensitive/marrow negative disease . Patients plan harvest hold may also include long criterion meet . Pregnancy Zubrod performance status great 2 Life expectancy severely limited concomitant illness . Uncontrolled arrhythmias symptomatic cardiac disease preclude transplantation Symptomatic pulmonary disease preclude transplantation Serum creatinine great 1.8 mg/dL Serum bilirubin great 2 X upper limit normal , SGPT great 3 time upper limit normal Evidence chronic active hepatitis cirrhosis Unable sign inform consent . Allergy Rituximab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>non-Hodgkins</keyword>
	<keyword>lymphoma</keyword>
	<keyword>stem cell transplant</keyword>
</DOC>